etravirine has been researched along with Chronic Hepatitis B in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clotet, B; Clumeck, N; Katlama, C; Nijs, S; Witek, J | 1 |
1 trial(s) available for etravirine and Chronic Hepatitis B
Article | Year |
---|---|
Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hepatitis C Antibodies; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Male; Nitriles; Placebos; Pyridazines; Pyrimidines | 2010 |